aTyr Pharma, Inc.
Quick facts
Phase 1 pipeline
- ATYR1940
ATYR1940 is designed to modulate immune and inflammatory responses involved in fibrotic disease processes.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies